A new mobile eye clinic has opened in Nursling, aiming to reduce NHS eye waiting times for Hampshire patients. The newly opened Practice Plus Group clinics in Nursling and another in Ringwood will ...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving ...

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially ...

Global Oncology Clinical Trial Market Demonstrates Steady Growth Amidst Rising Cancer Incidence and Technological Advancements The global Oncology Clinical Trial Market Size is experiencing consistent ...

Two new "sight-saving" eye clinics have been launched in Hampshire with new mobile clinics in Ringwood and Nursling.

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

The new approach from Brown uses gold nanorods injected into the eye's vitreous humor and incorporated into the retina, to ...

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80.

Retrospective Case Review Study Utilized AI-enriched Data Manassas, Virginia--(Newsfile Corp. - April 22, 2025) - Digital ...

Age-related macular degeneration begins with weakening of retinal pigment epithelium cells (RPEs), a layer of cells that support the retina's photoreceptors. When degeneration occurs, the affected ...